US Patent Issued to Alexion Pharmaceuticals on April 8 for "Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase" (Connecticut Inventor)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,733, issued on April 8, was assigned to Alexion Pharmaceuticals Inc. (Boston).

"Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase" was invented by Anna Petryk (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure features methods for treating at least one symptom of neurofibromatosis type 1, treating at least one symptom of dystrophic scoliosis, or inducing bone healing by administering a soluble alkaline phosphatase (sALP) to the patient."

The patent was filed on Aug. 9, 2019, under Application No. 17/265,894.

*For further information, including images, charts and tables, pleas...